Centogene N.V.
$0.33▲ 100.00%(+$0.33)
TickerSpark Score
50/100
▌ Mixed
60
Valuation
35
Profitability
25
Growth
52
Health
80
Momentum
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CNTG research report →
52-Week Range0% of range
Low
$0.33
Current
$0.33
High
$0.43
Company Overviewwww.centogene.com
About the company
Centogene N. V. , along with its affiliates, operates globally with a primary focus on rare diseases.
- CEO
- Kim Stratton
- IPO
- 2019
- Employees
- 384
- HQ
- Rostock, DE
Price Chart
-74.14% · this period
Valuation
- Market Cap
- $9.42M
- P/E
- -0.23
- P/S
- 0.17
- P/B
- -0.32
- EV/EBITDA
- -3.63
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 35.54%
- Op Margin
- -61.11%
- Net Margin
- -73.21%
- ROE
- 397.65%
- ROIC
- -47.95%
Growth & Income
- Revenue
- $48.54M · 2.24%
- Net Income
- $-35,532,000 · -11.59%
- EPS
- $-1.27 · -14.41%
- Op Income
- $-29,659,000
- FCF YoY
- -19.05%
Performance & Tape
- 52W High
- $0.43
- 52W Low
- $0.33
- 50D MA
- $0.16
- 200D MA
- $0.26
- Beta
- -0.67
- Avg Volume
- 431.57K
Get TickerSpark's AI analysis on CNTG
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Coverage · CNTG
Our CNTG coverage
Recent articles, reports, and earnings notes.
On-Demand Research
No research on CNTG yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CNTG report →Internal Compare
Similar companies
Peers in the same neighborhood.